[Treatment of vaginitis due to Trichomonas. Results with a new imidazole derivative: Nitrimidazine].
D000328:Adult; D000994:Antitrichomonal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003085:Colic / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011537:Pruritus / Q000139:chemically induced; D014247:Trichomonas Vaginitis / Q000188:drug therapy*
D000994:Antitrichomonal Agents; D009025:Morpholines; D009593:Nitroimidazoles
Trattamento della vaginite da tricomonas. Risultati con un nuovo composto imidazolico: la Nitrimidazina